ReviewSports (Basel, Switzerland)2022

Overuse of Short-Acting Beta-2 Agonists (SABAs) in Elite Athletes: Hypotheses to Explain It.

Nicolas Vertadier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.